Bio Protocol vs Synapse — how do they compare? Bio Protocol trades at Rp443.63 (market cap Rp1,01T, Rp176,29M 24h volume), while Synapse trades at Rp1,921 (market cap Rp450,03M, Rp185,75M 24h volume). The key difference: Bio Protocol is far larger — about 2244.3× Synapse's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 233,9M / 250M SYN (94%) for Synapse. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Synapse for 18 Days on average.
| BIO | SYN | |
|---|---|---|
Market Cap | Rp1,01T | Rp450,03M |
Volume (24h) | Rp176,29M | Rp185,75M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 233,9M / 250M SYN (94%) |
Typical Hold Time | 18 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Synapse (SYN) trades at Rp1,854 with neutral technical signals across oscillators and mixed moving averages. The token shows 94% circulating supply utilization with current price positioned between key support at Rp1,806 and resistance at Rp2,016. Market cap stands at Rp432.39M with moderate trading activity observed.
Overall outlook remains neutral with consolidation likely near current levels. Key opportunity lies in potential breakout above Rp2,016 resistance, while major risks include bearish moving average signals and limited recent ecosystem developments. Investors should monitor volume patterns for directional clues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Synapse is an interoperability protocol designed to safely and securely send arbitrary data between blockchains. Users can transfer and swap their assets across many chains, including layer 1, layer 2, and sidechain ecosystems. The project aims to improve inter-blockchain compatibility by helping users move their assets between networks more efficiently.
Read more on SYN →